Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis

Rheumatology

Volumn 39, Issue 5, 2000, Pages 481-489

  Vittecoq, O ^a   Jouen Beades, F ^a   Krzanowska, K ^a   Bichon Tauvel, I ^a   Menard, J F ^a   Daragon, A ^a   Gilbert, D ^a   Tron, F ^a   Le Loet X ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

ANCA; Anti 2 glycoprotein 1 antibodies; Anticardiolipin antibodies; Antilactoferrin antibodies; Rheumatoid arthritis

Indexed keywords

BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; LACTOFERRIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY TITER; ARTICLE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

EID: 0034094979     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.5.481     Document Type: Article

References (44)

1. Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am 1990;16:513-37.
2. Van Zeben D, Hazes JMW, Zwinderman AH, Cats A, van der Voort EAM, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow-up study. Ann Rheum Dis 1992;53:1029-35.
3. Aho K, Palusuo T, Kurki P. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications. Semin Arthritis Rheum 1994;23:379-87.
4. Vittecoq O, Jouen-Beades F, Delpech A, Gilbert D, Le Loët X, Tron F. Autoantibodies in rheumatoid arthritis. Rev Rhum [Engl. Ed] 1995;62:195S-200S.
5. Combe B, Eliaou JF, Daurès JP, Meyer O, Clot J, Sany J. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 1995;34:529-34.
6. Wagner U, Kaltenhauser S, Sauer H et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40:341-51.
7. Wattiaux MJ, Kahn MF, Bourgeois P, Vinceneux Ph, Grossin M, Kaplan G. Analyse anatomique et nosologiquc de 100 cas d'angéites diffuses vues en Rhumatologie. Rev Rhum Mal Osteoartic 1985;52:599-603.
8. Schultz DR, Tozman EC. Anti-neutrophil cyloplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin Arthritis Rheum 1995;25:143-59.
9. Lockshin MD. Palhogenesis of the antiphospholipid antibody syndrome. Lupus 1996;5:404-8.
10. 2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
11. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998;31:315-24.
12. Guillemin F, Briançon S, Pourel J. Mesure de la capacité fonctionnelle dans la polyarthrite rhumatoide: adaptation française du Health Assessment Questionnaire. Rev Rhum 1991;58:459-65.
13. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;97(Suppl. 6):12-3.
14. Harris EN. Special report. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Path 1990;94:476-84.
15. Nässberger L, Sjöholm AG, Sturfelt G. Absence of circulating antineutrophil cytoplasmic antibodies (ANCA) in severe vasculitis associated with rheumatoid arthritis. Scand J Rheumatol 1990;19:189-92.
16. Coremans IEM, Hagen EC. Daha MR et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
17. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical cor-relations. Arthritis Rheum 1993;36:1054-60.
18. Nässberger L, Hultquist R. Sturfelt G. Occurrence of anti-lactoferrin antibodies in patients with systemic lupus erythematosus, hydralazine-induced lupus, and rheumatoid arthritis. Scand J Rheumatol 1994;23:206 10.
19. Cambridge G, Williams M, Leaker B, Corbett M, Smith CR. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis 1994;53;24-9.
20. Helsloot J, Virgo S, McGuigan L, Sturgess A. Antineutrophil cytoplasmic antibodies in inflammatory arthritis-Potential for misdiagnosis ? Br J Rheumatol 1995;34:820-4.
21. Bosch X, Llena J, Collado A et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear anti-bodies in rheumatoid arthritis. J Rheumatol 1995;22:2038-45.
22. Braun MG, Csernok E, Schmitt WH, Gross WL. Incidence, target antigens. and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 1996;23:826-30.
23. Afeltra A, Sebastiani GD, Galeazzi M et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 1996;23:10-5.
24. de Bandt M, Meyer O, Haim T, Kahn MF. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients. Br J Rheumatol 1996;35:38-43.
25. Mustila A, Korpela M, Mustonen J et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis. A marker of severe disease with associated nephropathy. Arthritis Rheum 1997;40:710-7.
26. Fort JG, Cowchock FS, Abruzzo RL, Smith JB. Anticardiolipin antibodies in patients with rheumatic dis-eases. Arthritis Rheum 1987;30:752-60.
27. Keane A, Woods R, Dowding V, Roden D, Barry C. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol 1987;26:346-50.
28. Buchanan RR, Wardlaw JR, Riglar AG, Little John GO, Miller MH. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease. J Rheumatol 1989;16:757 61.
29. Seriolo B, Cutolo M, Fasciolo D, de Cesari F, Accardo S. Anticardiolipin antibodies in rheumatoid arthritis. Ann Rheum Dis 1992;51:1100.
30. Wolf P, Gretler J, Aglas F, Auer-Grumbach P, Rainer F. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Br J Dermatol 1994;131:48 51.
31. Merkel PA, Chang YC, Pierangeli SS, Convery K, Harris N, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576-83.
32. Wiik A. Granulocyte-specific antinuclear antibodies. Allergy 1980;35:263-89.
33. Schnabel A, Hauschild S, Gross WL. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Appl Immunol 1996;109:201 6.
34. Audrain MAP, Baranger AR, Lockwood CM, Esnault VLM. High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase. J Immunol Methods 1994;176:23-31.
35. Brimnes J, Halberg P, Jacobsen S, Wiik A, Heegard NHH. Specificities of anti-neutrophil antibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol 1997;110:250 6.
36. Savige JA, Gallichio MC, Stockman A, Cunningham TJ, Rowley MJ. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Clin Exp Immunol 1991;86:92 8.
37. Rabee SA, Sallam AM, Ayuoub NM, Kholy EE. Anticardiolipin antibodies in rheumatoid arthritis. J Egyptian Public Health Assoc 1994;69:47 63.
38. Monteagudo M, Montalban J, Alvarez J, Lima J, Garcia-Bragado F, Barquinero J. Stroke and anticardiolipin anti-bodies in a patient with rheumatoid arthritis and large granular lymphocyte proliferation. J Rheumatol 1988;15:1589-90.
39. Voisin L, Dérumeaux G, Borg JY et al. Catastrophic antiphospholipid syndrome with fatal acute course in rheumatoid arthritis. J Rheumatol 1995;22:1586 8.
40. Seriolo B, Accardo S, Fasciolo D, Sulli A, Bertolini D, Cutolo M. Lipoprotein (a) and anticardiolipin antibodies as risk factors for vascular disease in rheumatoid arthritis. Thromb Haemostasis 1995;74:799-800.
41. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Matsuura E, Ikeda Y. Disease distribution of beta 2-glycoprotcin 1-dependent anticardiolipin antibodies in rheumatic diseases. Lupus 1995;4:27S 31S.
42. 2-glycoprotein 1 and cardiolipin. J Immunol 1996;156:2631-41.
43. Hashimoto Y, Kawamura M, Ichkawa K et al. Anticardiolipin antibodies in NZW × BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol 1992;149:1063-8.
44. Finnern R, Bye JM, Dolman KM et al. Molecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries. Clin Exp Immunol 1995;102:566-74.